
Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates
Keywords: 17β استرادیول; Anastrozole; Bone loss; Bone turnover marker; 17β-Estradiol; Risedronate;